|
Death care
Appeared before the Federal Trade Commission (FTC) to present analysis of the antitrust
implications of proposed mergers in the death care industry at both the manufacturer and
distributor levels. Analyses relied on extensive investigations into industry practices,
using natural experiments that involved rigorous statistical analysis and retrospective
merger analysis. Provided significant assistance to attorneys in responding to a request
for additional information from the FTC.
|
